Intracerebroventricular administration of vasoactive intestinal peptide inhibits food intake

Regulatory Peptides

Volumn 172, Issue 1-3, 2011, Pages 8-15

  Ghourab, Samar ^a   Beale, Kylie E ^a   Semjonous, Nina M ^a   Simpson, Katherine A ^a   Martin, Niamh M ^a   Ghatei, Mohammad A ^a   Bloom, Stephen R ^a   Smith, Kirsty L ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Energy homeostasis; Food intake; Hypothalamus

Indexed keywords

AGOUTI RELATED PROTEIN; ALPHA INTERMEDIN; CARBON DIOXIDE; COCAINE AND AMPHETAMINE REGULATED TRANSCRIPT PEPTIDE; N ACETYL ALPHA INTERMEDIN[4-10]CYCLO[4 NORLEUCINE 5 ASPARTIC ACID 7 [3 (2 NAPHTHYL)ALANINE] 10 LYSINAMIDE]; NEUROPEPTIDE Y; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANOREXIGENIC EFFECT; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; ENERGY BALANCE; ENERGY EXPENDITURE; FOOD INTAKE; GROOMING; HYPOTHALAMUS; LOCOMOTION; LUNG GAS EXCHANGE; MALE; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEIN SECRETION; RAT;

ANIMALS; BEHAVIOR, ANIMAL; EATING; ENERGY METABOLISM; INJECTIONS, INTRAVENTRICULAR; MALE; MELANOCYTE-STIMULATING HORMONES; RATS; RATS, WISTAR; VASOACTIVE INTESTINAL PEPTIDE;

MAMMALIA; RATTUS NORVEGICUS; VERTEBRATA;

EID: 80053562370     PISSN: 01670115     EISSN: 18731686     Source Type: Journal    
DOI: 10.1016/j.regpep.2011.07.006     Document Type: Article

References (61)

1. Sherwood N.M., Krueckl S.L., McRory J.E. The origin and function of the pituitary adenylate cyclase-activating polypeptide (PACAP)/glucagon superfamily. Endocr Rev 2000, 21:619-670.
2. Said S.I., Mutt V. Polypeptide with broad biological activity: isolation from small intestine. Science 1970, 169:1217-1218.
3. Said S.I., Mutt V. Isolation from porcine-intestinal wall of a vasoactive octacosapeptide related to secretin and to glucagon. Eur J Biochem 1972, 28:199-204.
4. Schutzberg M., Hokfelt T., Lundberg J.M., Fuxe K., Mutt V., Said S. Distribution of VIP neurons in the peripheral and central nervous system. Endocrinol Jpn 1980, 27(Suppl. 1):23-30.
5. Henning R.J., Sawmiller D.R. Vasoactive intestinal peptide: cardiovascular effects. Cardiovasc Res 2001, 49:27-37.
6. Lam K.S. Vasoactive intestinal peptide in the hypothalamus and pituitary. Neuroendocrinology 1991, 53(Suppl. 1):45-51.
7. Hill J.M., Glazner G.W., Lee S.J., Gozes I., Gressens P., Brenneman D.E. Vasoactive intestinal peptide regulates embryonic growth through the action of activity-dependent neurotrophic factor. Ann N Y Acad Sci 1999, 897:92-100.
8. Dejda A., Sokolowska P., Nowak J.Z. Neuroprotective potential of three neuropeptides PACAP, VIP and PHI. Pharmacol Rep 2005, 57:307-320.
9. Naruse S., Inoue T., Mochizuki T., Yanaihara N. Vasodilator action of guinea pig vasoactive intestinal polypeptide (VIP): comparison with common mammalian VIP. Regul Pept 1992, 42:163-171.
10. Makhlouf G.M., Murthy K.S. Signal transduction in gastrointestinal smooth muscle. Cell Signal 1997, 9:269-276.
11. Linden A., Cardell L.O., Yoshihara S., Nadel J.A. Bronchodilation by pituitary adenylate cyclase-activating peptide and related peptides. Eur Respir J 1999, 14:443-451.
12. Lundberg P., Bostrom I., Mukohyama H., Bjurholm A., Smans K., Lerner U.H. Neuro-hormonal control of bone metabolism: vasoactive intestinal peptide stimulates alkaline phosphatase activity and mRNA expression in mouse calvarial osteoblasts as well as calcium accumulation mineralized bone nodules. Regul Pept 1999, 85:47-58.
13. Nussdorfer G.G., Malendowicz L.K. Role of VIP, PACAP, and related peptides in the regulation of the hypothalamo-pituitary-adrenal axis. Peptides 1998, 19:1443-1467.
14. Vosko A.M., Schroeder A., Loh D.H., Colwell C.S. Vasoactive intestinal peptide and the mammalian circadian system. Gen Comp Endocrinol 2007, 152:165-175.
15. Yamagami T., Ohsawa K., Nishizawa M., Inoue C., Gotoh E., Yanaihara N., Yamamoto H., Okamoto H. Complete nucleotide sequence of human vasoactive intestinal peptide/PHM-27 gene and its inducible promoter. Ann N Y Acad Sci 1988, 527:87-102.
16. Fahrenkrug J. Co-existence and co-secretion of the structurally related peptides VIP and PHI. Scand J Clin Lab Invest Suppl 1987, 186:43-50.
17. Moriarty K.J., Hegarty J.E., Tatemoto K., Mutt V., Christofides N.D., Bloom S.R., Wood J.R. Effect of peptide histidine isoleucine on water and electrolyte transport in the human jejunum. Gut 1984, 25:624-628.
18. Inoue T., Kato Y., Koshiyama H., Yanaihara N., Imura H. Interaction between vasoactive intestinal polypeptide (VIP) and peptide histidine isoleucine (PHI) in stimulating the secretion of prolactin from rat anterior pituitary cells in vitro. Neurosci Lett 1988, 85:363-369.
19. Suzuki Y., Satoh S., Lederis K., Rorstad O. Cerebral vascular effects of peptide histidine methionine in canine and bovine species. Pharmacology 1991, 42:241-245.
20. Dussaillant M., Sarrieau A., Gozes I., Berod A., Rostene W. Distribution of cells expressing vasoactive intestinal peptide/peptide histidine isoleucine-amide precursor messenger RNA in the rat brain. Neuroscience 1992, 50:519-530.
21. Laburthe M., Couvineau A., Marie J.C. VPAC receptors for VIP and PACAP. Receptors Channels 2002, 8:137-153.
22. Sheward W.J., Lutz E.M., Harmar A.J. The distribution of vasoactive intestinal peptide2 receptor messenger RNA in the rat brain and pituitary gland as assessed by in situ hybridization. Neuroscience 1995, 67:409-418.
23. Usdin T.B., Bonner T.I., Mezey E. Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions. Endocrinology 1994, 135:2662-2680.
24. Berthoud H.R. Multiple neural systems controlling food intake and body weight. Neurosci Biobehav Rev 2002, 26:393-428.
25. Matsuda K., Maruyama K., Nakamachi T., Miura T., Uchiyama M., Shioda S. Inhibitory effects of pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) on food intake in the goldfish, Carassius auratus. Peptides 2005, 26:1611-1616.
26. Tachibana T., Saito S., Tomonaga S., Takagi T., Saito E.S., Boswell T., Furuse M. Intracerebroventricular injection of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibits feeding in chicks. Neurosci Lett 2003, 339:203-206.
27. Olszewski P.K., Wirth M.M., Shaw T.J., Grace M.K., Levine A.S. Peptides that regulate food intake: effect of peptide histidine isoleucine on consummatory behavior in rats. Am J Physiol Regul Integr Comp Physiol 2003, 284:R1445-R1453.
28. Bechtold D.A., Brown T.M., Luckman S.M., Piggins H.D. Metabolic rhythm abnormalities in mice lacking VIP-VPAC2 signaling. Am J Physiol Regul Integr Comp Physiol 2008, 294:R344-R351.
29. Jozsa R., Nemeth J., Tamas A., Hollosy T., Lubics A., Jakab B., Olah A., Lengvari I., Arimura A., Reglodi D. Short-term fasting differentially alters PACAP and VIP levels in the brains of rat and chicken. Ann N Y Acad Sci 2006, 1070:354-358.
30. O'Shea D., Morgan D.G., Meeran K., Edwards C.M., Turton M.D., Choi S.J., Heath M.M., Gunn I., Taylor G.M., Howard J.K., Bloom C.I., Small C.J., Haddo O., Ma J.J., Callinan W., Smith D.M., Ghatei M.A., Bloom S.R. Neuropeptide Y induced feeding in the rat is mediated by a novel receptor. Endocrinology 1997, 138:196-202.
31. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 2007, Academic Press, New York.
32. Semjonous N.M., Smith K.L., Parkinson J.R., Gunner D.J., Liu Y.L., Murphy K.G., Ghatei M.A., Bloom S.R., Small C.J. Coordinated changes in energy intake and expenditure following hypothalamic administration of neuropeptides involved in energy balance. Int J Obes (Lond) 2009, 33:775-785.
33. Abbott C.R., Kennedy A.R., Wren A.M., Rossi M., Murphy K.G., Seal L.J., Todd J.F., Ghatei M.A., Small C.J., Bloom S.R. Identification of hypothalamic nuclei involved in the orexigenic effect of melanin-concentrating hormone. Endocrinology 2003, 144:3943-3949.
34. Nicholson S.A., Adrian T.E., Bacarese-Hamilton A.J., Gillham B., Jones M.T., Bloom S.R. 24-hour variation in content and release of hypothalamic neuropeptides in the rat. Regul Pept 1983, 7:385-397.
35. Kim M.S., Small C.J., Stanley S.A., Morgan D.G., Seal L.J., Kong W.M., Edwards C.M., Abusnana S., Sunter D., Ghatei M.A., Bloom S.R. The central melanocortin system affects the hypothalamo-pituitary thyroid axis and may mediate the effect of leptin. J Clin Invest 2000, 105:1005-1011.
36. Murphy K.G., Abbott C.R., Mahmoudi M., Hunter R., Gardiner J.V., Rossi M., Stanley S.A., Ghatei M.A., Kuhar M.J., Bloom S.R. Quantification and synthesis of cocaine- and amphetamine-regulated transcript peptide (79-102)-like immunoreactivity and mRNA in rat tissues. J Endocrinol 2000, 166:659-668.
37. Liu Y.L., Malik N., Sanger G.J., Friedman M.I., Andrews P.L. Pica-a model of nausea? Species differences in response to cisplatin. Physiol Behav 2005, 85:271-277.
38. Fray P.J., Sahakian B.J., Robbins T.W., Koob G.F., Iversen S.D. An observational method for quantifying the behavioural effects of dopamine agonists: contrasting effects of d-amphetamine and apomorphine. Psychopharmacology (Berl) 1980, 69:253-259.
39. Mounien L., Do Rego J.C., Bizet P., Boutelet I., Gourcerol G., Fournier A., Brabet P., Costentin J., Vaudry H., Jegou S. Pituitary adenylate cyclase-activating polypeptide inhibits food intake in mice through activation of the hypothalamic melanocortin system. Neuropsychopharmacology 2009, 34:424-435.
40. Hawke Z., Ivanov T.R., Bechtold D.A., Dhillon H., Lowell B.B., Luckman S.M. PACAP neurons in the hypothalamic ventromedial nucleus are targets of central leptin signaling. J Neurosci 2009, 29:14828-14835.
41. Wren A.M., Small C.J., Abbott C.R., Jethwa P.H., Kennedy A.R., Murphy K.G., Stanley S.A., Zollner A.N., Ghatei M.A., Bloom S.R. Hypothalamic actions of neuromedin U. Endocrinology 2002, 143:4227-4234.
42. Stothers J.K., Warner R.M. Effect of feeding on neonatal oxygen consumption. Arch Dis Child 1979, 54:415-420.
43. Matsuda K., Maruyama K., Nakamachi T., Miura T., Shioda S. Effects of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide on food intake and locomotor activity in the goldfish, Carassius auratus. Ann N Y Acad Sci 2006, 1070:417-421.
44. Tachibana T., Oikawa D., Adachi N., Boswell T., Furuse M. Central administration of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide differentially regulates energy metabolism in chicks. Comp Biochem Physiol A Mol Integr Physiol 2007, 147:156-164.
45. Hahn T.M., Breininger J.F., Baskin D.G., Schwartz M.W. Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons. Nat Neurosci 1998, 1:271-272.
46. Elias C.F., Saper C.B., Maratos-Flier E., Tritos N.A., Lee C., Kelly J., Tatro J.B., Hoffman G.E., Ollmann M.M., Barsh G.S., Sakurai T., Yanagisawa M., Elmquist J.K. Chemically defined projections linking the mediobasal hypothalamus and the lateral hypothalamic area. J Comp Neurol 1998, 402:442-459.
47. Jacobowitz D.M., O'Donohue T.L. alpha-Melanocyte stimulating hormone: immunohistochemical identification and mapping in neurons of rat brain. Proc Natl Acad Sci USA 1978, 75:6300-6304.
48. Elmquist J.K., Ahima R.S., Elias C.F., Flier J.S., Saper C.B. Leptin activates distinct projections from the dorsomedial and ventromedial hypothalamic nuclei. Proc Natl Acad Sci USA 1998, 95:741-746.
49. Fekete C., Legradi G., Mihaly E., Huang Q.H., Tatro J.B., Rand W.M., Emerson C.H., Lechan R.M. alpha-Melanocyte-stimulating hormone is contained in nerve terminals innervating thyrotropin-releasing hormone-synthesizing neurons in the hypothalamic paraventricular nucleus and prevents fasting-induced suppression of prothyrotropin-releasing hormone gene expression. J Neurosci 2000, 20:1550-1558.
50. Cowley M.A., Pronchuk N., Fan W., Dinulescu D.M., Colmers W.F., Cone R.D. Integration of NPY, AGRP, and melanocortin signals in the hypothalamic paraventricular nucleus: evidence of a cellular basis for the adipostat. Neuron 1999, 24:155-163.
51. Kalra S.P., Dube M.G., Pu S., Xu B., Horvath T.L., Kalra P.S. Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr Rev 1999, 20:68-100.
52. Mounien L., Bizet P., Boutelet I., Gourcerol G., Fournier A., Vaudry H., Jegou S. Pituitary adenylate cyclase-activating polypeptide directly modulates the activity of proopiomelanocortin neurons in the rat arcuate nucleus. Neuroscience 2006, 143:155-163.
53. Poplawski M.M., Boyadjieva N., Sarkar D.K. Vasoactive intestinal peptide and corticotropin-releasing hormone increase beta-endorphin release and proopiomelanocortin messenger RNA levels in primary cultures of hypothalamic cells: effects of acute and chronic ethanol treatment. Alcohol Clin Exp Res 2005, 29:648-655.
54. Kim B. Thyroid hormone as a determinant of energy expenditure and the basal metabolic rate. Thyroid 2008, 18:141-144.
55. Fan W., Boston B.A., Kesterson R.A., Hruby V.J., Cone R.D. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 1997, 385:165-168.
56. Harmar A.J., Arimura A., Gozes I., Journot L., Laburthe M., Pisegna J.R., Rawlings S.R., Robberecht P., Said S.I., Sreedharan S.P., Wank S.A., Waschek J.A. International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmacol Rev 1998, 50:265-270.
57. Murase T., Kondo K., Arima H., Iwasaki Y., Ito M., Miura Y., Oiso Y. The expression of pituitary adenylate cyclase-activating polypeptide (PACAP) mRNA in rat brain: possible role of endogenous PACAP in vasopressin release. Neurosci Lett 1995, 185:103-106.
58. Joo K.M., Chung Y.H., Kim M.K., Nam R.H., Lee B.L., Lee K.H., Cha C.I. Distribution of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide receptors (VPAC1, VPAC2, and PAC1 receptor) in the rat brain. J Comp Neurol 2004, 476:388-413.
59. Aton S.J., Colwell C.S., Harmar A.J., Waschek J., Herzog E.D. Vasoactive intestinal polypeptide mediates circadian rhythmicity and synchrony in mammalian clock neurons. Nat Neurosci 2005, 8:476-483.
60. Brown T.M., Colwell C.S., Waschek J.A., Piggins H.D. Disrupted neuronal activity rhythms in the suprachiasmatic nuclei of vasoactive intestinal polypeptide-deficient mice. J Neurophysiol 2007, 97:2553-2558.
61. Asnicar M.A., Koster A., Heiman M.L., Tinsley F., Smith D.P., Galbreath E., Fox N., Ma Y.L., Blum W.F., Hsiung H.M. Vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating peptide receptor 2 deficiency in mice results in growth retardation and increased basal metabolic rate. Endocrinology 2002, 143:3994-4006.